Last reviewed · How we verify
NCT03945474
Osteopathic Manipulation in Breastfed Newborns
NA trial testing Sham in Osteopathic Medicine in 80 participants. Status unknown.
31 October 2019
Quick facts
| Lead sponsor | Methodist Medical Center of Illinois |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 10 October 2017 |
| Primary completion | 31 October 2019 |
| Estimated completion | 31 October 2019 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Sham
- Osteopathic Manipulation, OMT
Conditions studied
- Osteopathic Medicine — all drugs for Osteopathic Medicine →
- Breast Feeding — all drugs for Breast Feeding →
Sponsor
Methodist Medical Center of Illinois
Who can join
Adults 20 Hours to 2 Weeks, any sex, with Osteopathic Medicine or Breast Feeding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Osteopathic manipulative treatment(OMT) is a form of manual medicine in which a trained physician uses his or her hands to diagnose areas of restriction in a patient's body. The physician then uses his or her hands to manually correct the restriction, to improve body function. The research team will be performing OMT on breastfed newborns that have been identified by lactation consultants as having a feeding issues. The team will then compare the feeding behaviors of these babies to those in the same category who did not receive OMT. OMT has some similarities to chiropractic manipulation. No thrusting techniques that produce a popping or cracking sound, as traditionally associated with chiropractic, will be used in this study. Infants will be assigned to either the OMT group or No OMT group by the research team using a randomized process to help ensure equal enrollment in both groups. All babies will receive standard lactation support. All newborns receiving OMT will undergo the same four treatments, all of which involve light touch and massage. All newborns not receiving OMT will undergo a gentle application of light touch but no treatment. OMT treatment or sham sessions will be brief, taking no longer than 10 minutes, with each infant receiving two sessions during the study. During breastfeeding sessions, a lactation consultant will assess the infant's breastfeeding behavior using a tool called the LATCH score. He/she will be scored upon enrolling in the study, daily during hospitalization and before discharge from the hospital. The breastfeeding scores of the newborns who received OMT will be compared to the scores of those who did not. The following is information regarding the types of treatment the investigators will use in the study:All treatments will be done with the baby lying on his or her back and will be gentle, applying no more force than would be used to test a tomato for ripeness. The provider's touch will be delicate enough so as not to blanch his or her fingernail beds while treating the infant. The first technique will reduce tightness in the sternocleidomastoid muscle, a front neck muscle that bends the head to one side and rotates the head the opposite side. The second technique treatment is used to correct tightness at the occipital condyle, which is the joint formed by the bone at the base of the skull and the top vertebrae of the neck. The hyoid bone is located in the neck and it aids in tongue movement and swallowing. The practitioner will apply gentle motion to the hyoid bone, usually using a finger and thumb. In the last technique, the physician will apply gentle motion to the connective tissue circling the baby's upper chest, shoulders, upper back, and lower neck, typically using the thumb and a few fingers on each hand. The purpose of this study is to determine whether osteopathic manipulative treatment (OMT) as an adjunct to lactation support will improve outcomes in breastfed newborns with feeding dysfunction.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Support for healthy breastfeeding mothers with healthy term babies.
Gavine A, Shinwell SC, Buchanan P, Farre A, et al · · 2022 · cited 84× · PMID 36282618 · DOI 10.1002/14651858.cd001141.pub6
Verify or expand the search:
- PubMed search for NCT03945474
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Sham
Trials testing the same drug.
- NCT06443177 — The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid Hemorrhage · NA · not yet recruiting
- NCT07450677 — Sensory Substitution and Brain Plasticity Following Vision Loss · NA · not yet recruiting
- NCT07524010 — Multi-Omics Characterization of Percutaneous Electrolysis in Low Back Pain · Phase 1 · enrolling by invitation
- NCT07486323 — Combined Non-Invasive Brain and Visual Stimulation for Vision Improvement · NA · not yet recruiting
- NCT07341971 — Effect of Non-invasive Vagal Nerve Stimulation on Selected Outcomes in Central Obesity · NA · not yet recruiting
Other Methodist Medical Center of Illinois trials
Trials by the same sponsor.
- NCT05221164 — 162 mg of Aspirin for Prevention of Preeclampsia · Phase 4 · unknown
- NCT03155594 — CGM to Aid Transition From Inpatient to Outpatient · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03945474 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Methodist Medical Center of Illinois
- Last refreshed: 10 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03945474.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing